Hemangioma, Capillary clinical trials
The registry lists 33 studies for Hemangioma, Capillary across more than 10 countries. 5 are recruiting or about to start. 31 of them are mainly about Hemangioma, Capillary (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-21.
Get an email when these change. Save the Hemangioma, Capillary studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
West China Hospital (6) · The Hospital for Sick Children (2) · Pierre Fabre Dermatology (2) · Assiut University (1) · Daniel Benjamin (1) · St. Justine's Hospital (1) · Ain Shams University (1) · The University of Texas Health Science Center, Houston (1)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Jun 2027Screening LUMBAR Syndrome in Infants With Infantile Hemangiomas · West China Hospital
Who these studies take
Of the 2 Hemangioma, Capillary studies recruiting now, 0 (0%) set no upper age limit and 2 (100%) stop at 75 or younger. 2 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 0 (0%) | 0 (0%) |
| 30 | 0 (0%) | 0 (0%) |
| 40 | 0 (0%) | 0 (0%) |
| 50 | 0 (0%) | 0 (0%) |
| 65 | 0 (0%) | 0 (0%) |
| 75 | 0 (0%) | 0 (0%) |
| 85 | 0 (0%) | 0 (0%) |
Across all 33 studies, recruiting or not: 97% stop at 75 or younger and 97% at 65; 100% take children; 0% are for women only and 0% for men only; 15% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 33 of 33. search them.
- Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile HemangiomaRecruitingNCT06798363Phase 2/31 country
- Risk Stratification and Treatment Decisions in Infantile Hemangioma With Minimal or Arrested GrowthNot yet recruitingNCT076695451 country
- Abrupt Discontinuation Versus Gradual Tapering of Propranolol in Infantile HemangiomaNot yet recruitingNCT07665177Phase 41 country
- Screening LUMBAR Syndrome in Infants With Infantile HemangiomasNot yet recruitingNCT076163231 country
- Clinical Characteristics of Infantile HemangiomaRecruitingNCT033317441 country
- Propranolol in Capillary HemangiomasTerminatedNCT00744185Phase 2/31 country
- Oral Propranolol Versus Fractional Carbon Dioxide CO2 Laser Assisted Delivery of Topical Timolol for Treatment of Infantile HemangiomaCompletedNCT07560332Not applicable1 country
- Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile HemangiomasTerminatedNCT05479123Phase 41 country
- Low-Dose Propranolol and Bleomycin for Infantile Hemangioma (IH)CompletedNCT07104526Not applicable1 country
- Timolol Maleate Gel for the Treatment of Infantile HemangiomaCompletedNCT06677853Phase 2/31 country
- Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)CompletedNCT02913612Phase 21 country
- Efficacy of Intralesional Bleomycin Alone and in Combination With Dexamethasone in Infantile HaemangiomasCompletedNCT06080724Not applicable1 country
- Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareCompletedNCT014313265 countries
- Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile HemangiomaCompletedNCT02342275Phase 31 country
- Infantile Hemangioma With Minimal or Arrested Growth : Epidemiology, Clinical Characteristics and EvolutionCompletedNCT050808681 country
- Nadolol for Proliferating Infantile HemangiomasCompletedNCT01010308Phase 21 country
- ''Efficacy of Propranolol in the Treatment of Infantile Hemangioma"Status unknownNCT04684667Phase 21 country
- Hemangiol, Post Marketing Surveillance StudyCompletedNCT041055171 country
- Nadolol Versus Propranolol in Children With Infantile HemangiomasCompletedNCT02505971Phase 31 country
- Evaluation of the Efficacy of Captopril Versus Propranolol and Timolol as a Treatment of Infantile Capillary HemangiomaStatus unknownNCT04288700Phase 41 country
- Optimizing Timolol Maleate Treatment of Infantile Hemangioma by Doppler Ultrasound ExaminationStatus unknownNCT038426311 country
- Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile HemangiomasStatus unknownNCT03237637Phase 31 country
- Optical Tomographic Imaging of Infantile HemangiomasCompletedNCT016739711 country
- Genetic Basis of HemangiomasTerminatedNCT004663751 country
- Topical Timolol 0.5% Solution for Proliferating Infantile HemangiomasTerminatedNCT01147601Early Phase 11 country
- A Prospective Study on the Incidence and Related Risk Factors of Infantile Hemangioma in ChinaStatus unknownNCT031733521 country
- Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial)TerminatedNCT01434849Phase 11 country
- Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic TherapyCompletedNCT01056341Phase 2/316 countries
- Ontogeny of Infantile Hemangiomas With Skin Imaging ModalitiesCompletedNCT020617351 country
- Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to PlaceboCompletedNCT01512173Phase 23 countries
- Timolol Option for Ulcerated Hemangiomas (TOUCH Trial)WithdrawnNCT01408056Phase 21 country
- Hemangioma Growth During the First 6 Months of LifeCompletedNCT009117811 country
- A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in InfancyCompletedNCT00601016Phase 21 country